ValitaCell shortlisted for prestigious innovation award

ValitaCell’s Quantum ‘At-line’ innovation was shortlisted by the Irish Times expert panel for the Innovation of the Year Award for 2020. ValitaCell’s Quantum ‘At-line’ technology enables biopharmaceutical companies to analyse the quality and quantity of their cell samples in real-time at the bioreactor, dramatically saving time and money.

The manufacturing process of innovative medicines for a clinical trial or market launch can cost millions and these medicines are extremely challenging to manufacture. Quantum ‘At-line’ technology is directly integrated at the bioreactor, enabling rapid and accurate analysis. 

The lead scientists and inventors of the Quantum technology are: Dr. Hannah Byrne, Head of Biological Science and Dr. Ben Thompson, Chief Technology Officer. 

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!